Q1 2025 Arkema SA Earnings Call Transcript
Key Points
- Arkema SA (ARKAF) demonstrated resilience in its Specialty Materials segment, which represents 93% of total sales, with only a 3% decline in EBITDA despite challenging market conditions.
- The Advanced Materials segment saw a 7% increase in EBITDA, driven by strong growth in high-performance polymers, particularly in Asia.
- The integration of Dow Adhesives is progressing well, with expectations of significant development and synergies over the next five years.
- Arkema SA (ARKAF) is making progress on major projects, including the ramp-up of the 1233zd unit in the US and the greenfield polyamide 11 plant in Singapore, which is expected to exceed breakeven by summer.
- A long-term agreement with ENGIE for biomethane supply will cover 85% of Bostik's gas consumption in France, contributing to Arkema SA (ARKAF)'s CO2 reduction goals.
- The macroeconomic environment remains difficult, with volatility and uncertainty, particularly due to trade tariffs affecting customer demand in the US.
- Intermediates, which account for 7% of sales, experienced a significant decline due to weak refrigerant gases, expected to remain weak into the second quarter.
- The Adhesives segment faced weak demand in Europe and North America, impacting EBITDA margins, which were diluted by the integration of Dow Adhesives.
- Coating Solutions continued to face low market conditions, particularly in upstream acrylics, affecting segment performance.
- The company anticipates continued pressure from unfavorable foreign exchange rates and the indirect impact of tariffs on global demand.
Welcome to Arkema's first quarter 2025 results and outlook conference call. For your information, this call is being recorded. (Operator Instructions)
I will now hand you over to Thierry Le Henaff, Chairman and Chief Executive Officer. Sir, please go ahead.
© -
Thank you very much. Good morning, everybody. So welcome to Arkema's Q1 2025 Results Conference Call. Joining me today are Marie Jose Donsion, our CFO; and the Investor Relations team. As always, to support this conference call, we have posted a set of slides, which are available on our website.
I will comment now the highlights of the quarter before letting Marie Jose go through the financials. And at the end of the presentation, we'll be available to answer your questions as usual. After a challenging macro in 2024 during which Arkema delivered a good performance, the market environment in Q1 2025 remains difficult with volatility and also a lack of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
